Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4849 | XCUR Exicure, Inc. - Common Stock | 1.14 USD | -0.87% | -11.63% | -33.72% | -81.00% | 7.46 M USD | ||
| 4852 | ALZN Alzamend Neuro, Inc. - Common Stock | 1.46 USD | -6.41% | -5.81% | +8.15% | -40.41% | 7.00 M USD | ||
| 4856 | CURX Curanex Pharmaceuticals Inc - Common Stock | 4.58 USD | -2.76% | +1981.82% | +2190.00% | +20.53% | 7.18 M USD | ||
| 4860 | ENSC Ensysce Biosciences, Inc. - Common Stock | 0.36 USD | -2.70% | -7.69% | +38.46% | -5.26% | 7.00 M USD | ||
| 4862 | BOLT Bolt Biotherapeutics, Inc. - Common Stock | 3.78 USD | +3.00% | +15.24% | -5.97% | -26.46% | 7.28 M USD | ||
| 4866 | LIMN Liminatus Pharma, Inc. - Class A Common Stock | 4.88 USD | -5.24% | +3385.71% | +4336.36% | +48.78% | 6.55 M USD | ||
| 4873 | IMRN Immuron Limited - American Depositary Shares | 1.14 USD | 0.00% | +2.70% | +1.79% | -36.67% | 6.67 M USD | ||
| 4880 | XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 2.76 USD | 0.00% | +4.15% | -3.50% | +206.67% | 6.53 M USD | ||
| 4886 | ENVB Enveric Biosciences, Inc. - Common Stock | 1.40 USD | -2.10% | -3.45% | +6.06% | -43.09% | 6.27 M USD | ||
| 4887 | NCNA NuCana plc - American Depositary Shares | 1.49 USD | -1.97% | -2.61% | +9.56% | -30.70% | 6.20 M USD | ||
| 4894 | ADXN Addex Therapeutics Ltd - American Depositary Shares | 4.50 USD | -8.91% | -23.34% | -22.41% | -43.04% | 5.54 M USD | ||
| 4900 | CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.93 USD | -4.93% | -5.39% | +25.32% | -26.34% | 5.71 M USD | ||
| 4910 | PCSA Processa Pharmaceuticals, Inc. - Common Stock | 2.07 USD | -0.48% | -8.81% | -23.05% | -6.76% | 5.78 M USD | ||
| 4914 | BGMS Bio Green Med Solution, Inc. - Common Stock | 0.88 USD | +1.15% | -4.35% | -2.22% | -85.33% | 5.83 M USD | ||
| 4915 | CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.64 USD | +1.86% | -7.34% | -23.36% | -70.29% | 5.85 M USD | ||
| 4918 | DRMA Dermata Therapeutics, Inc. - Common Stock | 1.43 USD | +0.70% | +2.88% | +11.72% | 0.00% | 5.75 M USD | ||
| 4921 | PMCB PharmaCyte Biotech, Inc. - Common Stock | 0.53 USD | 0.00% | -3.64% | -11.67% | -44.21% | 5.69 M USD | ||
| 4924 | BRTX BioRestorative Therapies, Inc. - Common Stock | 0.23 USD | +4.55% | 0.00% | -20.69% | -84.97% | 5.86 M USD | ||
| 4929 | PULM Pulmatrix, Inc. - Common Stock | 1.43 USD | -4.67% | -5.30% | -12.80% | -70.70% | 5.22 M USD | ||
| 4932 | BCAB BioAtla, Inc. - Common Stock | 3.41 USD | +5.25% | +10.00% | +2.10% | +847.22% | 5.68 M USD |
Nouvelles Biotechnology Stocks
Deutsche Bank dégrade argenx de Achat à Conserver en raison de la valorisation
Pourquoi l’action Monte Rosa Therapeutics chute-t-elle aujourd’hui ?
L’action Biomea Fusion bondit après la fin du recrutement pour son essai sur le diabète
L’action Monte Rosa chute au lancement d’une étude de phase 2 sur le cancer de la prostate
L’action Crinetics Pharmaceuticals atteint un record historique à 84,8 USD
H.C. Wainwright maintient sa recommandation sur Biomea Fusion après l’enrôlement
La FDA prolonge l’examen du deramiocel de Capricor au 22 novembre
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
OABIW OmniAb, Inc. - Warrant | 0.2339 | +37.59% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
Losers Biotechnology Stocks
HUMAW Humacyte, Inc. - Warrant | 0.0050 | -44.44% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |
SNTI Senti Biosciences, Inc. - Common Stock | 0.35 | -10.26% |